{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:09:05Z","timestamp":1790881745264,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Italian College of General Practitioners and Primary Care"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s11739-022-03054-1","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T19:02:53Z","timestamp":1659207773000},"page":"2237-2244","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["To clarify the safety profile of paracetamol for home-care patients with COVID-19: a real-world cohort study, with nested case\u2013control analysis, in primary care"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4342-9128","authenticated-orcid":false,"given":"Francesco","family":"Lapi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ettore","family":"Marconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignazio","family":"Grattagliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Fornasari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Magni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierangelo","family":"Lora Aprile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Cricelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,30]]},"reference":[{"key":"3054_CR1","doi-asserted-by":"publisher","first-page":"e1003777","DOI":"10.1371\/JOURNAL.PMED.1003777","volume":"18","author":"J Elliott","year":"2021","unstructured":"Elliott J, Whitaker M, Bodinier B et al (2021) Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people. PLOS Med 18:e1003777. https:\/\/doi.org\/10.1371\/JOURNAL.PMED.1003777","journal-title":"PLOS Med"},{"key":"3054_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013705.PUB2","author":"J Dinnes","year":"2021","unstructured":"Dinnes J, Deeks JJ, Berhane S et al (2021) Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD013705.PUB2","journal-title":"Cochrane Database Syst Rev"},{"key":"3054_CR3","unstructured":"Home care for patients with suspected or confirmed COVID-19 and management of their contacts. https:\/\/www.who.int\/publications\/i\/item\/home-care-for-patients-with-suspected-novel-coronavirus-(ncov)-infection-presenting-with-mild-symptoms-and-management-of-contacts. Accessed 21 Feb 2022"},{"key":"3054_CR4","unstructured":"NICE Overview | COVID-19 rapid guideline: managing COVID-19 | Guidance | NICE. https:\/\/www.nice.org.uk\/guidance\/ng191. Accessed 20 Feb 2022"},{"key":"3054_CR5","unstructured":"CDC Treatments Your Healthcare Provider Might Recommend if You Are Sick | CDC. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/your-health\/treatments-for-severe-illness.html. Accessed 20 Feb 2022"},{"key":"3054_CR6","unstructured":"AIFA Medicines usable for treatment of COVID-19 disease | Italian Medicines Agency. https:\/\/www.aifa.gov.it\/en\/aggiornamento-sui-farmaci-utilizzabili-per-il-trattamento-della-malattia-covid19. Accessed 22 Feb 2022"},{"key":"3054_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/IDR13010028","author":"DG DrI","year":"2021","unstructured":"DrI DG, A R et al (2021) How to treat COVID-19 patients at home in the Italian context: an expert opinion. Infect Dis Rep. https:\/\/doi.org\/10.3390\/IDR13010028","journal-title":"Infect Dis Rep"},{"key":"3054_CR8","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/S40264-020-00965-W","volume":"43","author":"M Tuccori","year":"2020","unstructured":"Tuccori M, Convertino I, Ferraro S et al (2020) The impact of the COVID-19 \u201cInfodemic\u201d on drug-utilization behaviors: implications for pharmacovigilance. Drug Saf 43:699\u2013709. https:\/\/doi.org\/10.1007\/S40264-020-00965-W","journal-title":"Drug Saf"},{"key":"3054_CR9","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1002\/pds.5324","volume":"30","author":"S Enners","year":"2021","unstructured":"Enners S, Gradl G, Kieble M et al (2021) Utilization of drugs with reports on potential efficacy or harm on COVID-19 before, during, and after the first pandemic wave. Pharmacoepidemiol Drug Saf 30:1493\u20131503. https:\/\/doi.org\/10.1002\/pds.5324","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"3054_CR10","doi-asserted-by":"publisher","first-page":"5704","DOI":"10.1002\/jmv.27158","volume":"93","author":"S Pandolfi","year":"2021","unstructured":"Pandolfi S, Simonetti V, Ricevuti G, Chirumbolo S (2021) Paracetamol in the home treatment of early COVID-19 symptoms: a possible foe rather than a friend for elderly patients? J Med Virol 93:5704\u20135706","journal-title":"J Med Virol"},{"key":"3054_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100941","volume":"37","author":"F Suter","year":"2021","unstructured":"Suter F, Consolaro E, Pedroni S et al (2021) A simple, home-therapy algorithm to prevent hospitalisation for COVID-19 patients: a retrospective observational matched-cohort study. EClinicalMedicine 37:100941","journal-title":"EClinicalMedicine"},{"key":"3054_CR12","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/J.BIOCEL.2005.03.005","volume":"37","author":"S Dimova","year":"2005","unstructured":"Dimova S, Hoet PHM, Dinsdale D, Nemery B (2005) Acetaminophen decreases intracellular glutathione levels and modulates cytokine production in human alveolar macrophages and type II pneumocytes in vitro. Int J Biochem Cell Biol 37:1727\u20131737. https:\/\/doi.org\/10.1016\/J.BIOCEL.2005.03.005","journal-title":"Int J Biochem Cell Biol"},{"key":"3054_CR13","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/bcpt.13690","volume":"130","author":"S Pandolfi","year":"2022","unstructured":"Pandolfi S, Chirumbolo S, Ricevuti G et al (2022) Home pharmacological therapy in early COVID-19 to prevent hospitalization and reduce mortality: time for a suitable proposal. Basic Clin Pharmacol Toxicol 130:225\u2013239. https:\/\/doi.org\/10.1111\/bcpt.13690","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"3054_CR14","unstructured":"Battaggia A Un algoritmo terapeutico domiciliare per prevenire i ricoveri? I risultati possono essere dovuti a sbilanciamento e a errore random - E&P Repository. https:\/\/repo.epiprev.it\/index.php\/download\/un-algoritmo-terapeutico-domiciliare-per-prevenire-i-ricoveri-i-risultati-possono-essere-dovuti-a-sbilanciamento-e-a-errore-random\/. Accessed 21 Feb 2022"},{"key":"3054_CR15","volume-title":"Risk of SARS-CoV-2 Infection and COVID-19 Severity Associated With Exposure to Nonsteroidal Anti-Inflammatory Drugs: Systematic Review and Meta-Analysis","author":"L Prada","year":"2021","unstructured":"Prada L, Santos DC, Bai\u00e3o RA et al (2021) Risk of SARS-CoV-2 Infection and COVID-19 Severity Associated With Exposure to Nonsteroidal Anti-Inflammatory Drugs: Systematic Review and Meta-Analysis. J. Clin, Pharmacol"},{"key":"3054_CR16","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/BCP.12705","volume":"80","author":"JL Faillie","year":"2015","unstructured":"Faillie JL (2015) Indication bias or protopathic bias? Br J Clin Pharmacol 80:779\u2013780. https:\/\/doi.org\/10.1111\/BCP.12705","journal-title":"Br J Clin Pharmacol"},{"key":"3054_CR17","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/PDS.1360","volume":"16","author":"H Tamim","year":"2007","unstructured":"Tamim H, Tahami Monfared AA, LeLorier J (2007) Application of lag-time into exposure definitions to control for protopathic bias. Pharmacoepidemiol Drug Saf 16:250\u2013258. https:\/\/doi.org\/10.1002\/PDS.1360","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"3054_CR18","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/BCP.14514","volume":"87","author":"R Vaja","year":"2021","unstructured":"Vaja R, Chan JSK, Ferreira P et al (2021) The COVID-19 ibuprofen controversy: a systematic review of NSAIDs in adult acute lower respiratory tract infections. Br J Clin Pharmacol 87:776\u2013784. https:\/\/doi.org\/10.1111\/BCP.14514","journal-title":"Br J Clin Pharmacol"},{"key":"3054_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/pubmed\/21.3.299","volume":"21","author":"R Lawrenson","year":"1999","unstructured":"Lawrenson R, Williams T, Farmer R (1999) Clinical information for research; the use of general practice databases. J Public Health Med 21:299\u2013304","journal-title":"J Public Health Med"},{"key":"3054_CR20","unstructured":"Bianchini E, Brignoli O, Cricelli C VIII Report Health Search. Available at: http:\/\/healthsearch.it\/documenti\/Archivio\/Report\/VIIIReport_2013-2014\/index.html."},{"key":"3054_CR21","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2022.2019582","author":"F Lapi","year":"2021","unstructured":"Lapi F, Domnich A, Marconi E et al (2021) Predicting the risk of severe COVID-19 outcomes in primary care: development and validation of a vulnerability index for equitable allocation of effective vaccines. Expert Rev Vaccines. https:\/\/doi.org\/10.1080\/14760584.2022.2019582","journal-title":"Expert Rev Vaccines"},{"key":"3054_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2011.09.048","author":"F Lapi","year":"2012","unstructured":"Lapi F, Simonetti M, Michieli R et al (2012) Assessing 5-year incidence rates and determinants of osteoporotic fractures in primary care. Bone. https:\/\/doi.org\/10.1016\/j.bone.2011.09.048","journal-title":"Bone"},{"key":"3054_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.08.269","volume-title":"What is the actual epidemiology of familial hypercholesterolemia in Italy?","author":"V Guglielmi","year":"2016","unstructured":"Guglielmi V, Bellia A, Pecchioli S et al (2016) What is the actual epidemiology of familial hypercholesterolemia in Italy? Int J Cardiol, Evidence from a National Primary Care Database. https:\/\/doi.org\/10.1016\/j.ijcard.2016.08.269"},{"key":"3054_CR24","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/pubmed\/fdg060","volume":"25","author":"C Cricelli","year":"2003","unstructured":"Cricelli C, Mazzaglia G, Samani F et al (2003) Prevalence estimates for chronic diseases in Italy: exploring the differences between self-report and primary care databases. J Pub Health Med 25:254\u2013257","journal-title":"J Pub Health Med"},{"key":"3054_CR25","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1996.10476660","author":"NE Breslow","year":"1996","unstructured":"Breslow NE (1996) Statistics in epidemiology: the case-control study. J Am Stat Assoc. https:\/\/doi.org\/10.1080\/01621459.1996.10476660","journal-title":"J Am Stat Assoc"},{"key":"3054_CR26","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jclinepi.2014.11.010","volume":"68","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons KGM (2015) Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. J Clin Epidemiol 68:134\u2013143. https:\/\/doi.org\/10.1016\/j.jclinepi.2014.11.010","journal-title":"J Clin Epidemiol"},{"key":"3054_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/1536867X0800800103","volume":"8","author":"N Orsini","year":"2008","unstructured":"Orsini N, Bellocco R, Bottai M et al (2008) A tool for deterministic and probabilistic sensitivity analysis of epidemiologic studies. Stata J 8:29\u201348","journal-title":"Stata J"},{"key":"3054_CR28","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1002\/pds.5346","volume":"30","author":"M Hempenius","year":"2021","unstructured":"Hempenius M, Groenwold RHH, de Boer A et al (2021) Drug exposure misclassification in pharmacoepidemiology: sources and relative impact. Pharmacoepidemiol Drug Saf 30:1703\u20131715. https:\/\/doi.org\/10.1002\/pds.5346","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"3054_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/J.ECLINM.2021.100941","author":"F Suter","year":"2021","unstructured":"Suter F, Consolaro E, Pedroni S et al (2021) A simple, home-therapy algorithm to prevent hospitalisation for COVID-19 patients: a retrospective observational matched-cohort study. EClinicalMedicine. https:\/\/doi.org\/10.1016\/J.ECLINM.2021.100941","journal-title":"EClinicalMedicine"},{"key":"3054_CR30","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/bcpt.13650","volume":"129","author":"S Pandolfi","year":"2021","unstructured":"Pandolfi S, Chirumbolo S (2021) Home therapy of COVID-19 at the earliest may greatly prevent hospitalization. Basic Clin Pharmacol Toxicol 129:395\u2013396. https:\/\/doi.org\/10.1111\/bcpt.13650","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"3054_CR31","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S0016-5085(75)80025-4","volume":"68","author":"JR Mitchell","year":"1975","unstructured":"Mitchell JR, Jollows DJ (1975) Metabolic activation of drugs to toxic substances. Gastroenterology 68:392\u2013410. https:\/\/doi.org\/10.1016\/S0016-5085(75)80025-4","journal-title":"Gastroenterology"},{"key":"3054_CR32","first-page":"297","volume":"3","author":"S Kennon-McGill","year":"2018","unstructured":"Kennon-McGill S, McGill MR (2018) Extrahepatic toxicity of acetaminophen: critical evaluation of the evidence and proposed mechanisms. J Clin Transl Res 3:297\u2013310","journal-title":"J Clin Transl Res"},{"key":"3054_CR33","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.joca.2016.01.008","volume":"24","author":"J Ranstam","year":"2016","unstructured":"Ranstam J (2016) Multiple P-values and Bonferroni correction. Osteoarthr Cartil 24:763\u2013764. https:\/\/doi.org\/10.1016\/j.joca.2016.01.008","journal-title":"Osteoarthr Cartil"},{"key":"3054_CR34","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/pds.1200","volume":"15","author":"S Schneeweiss","year":"2006","unstructured":"Schneeweiss S (2006) Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics. Pharmacoepidemiol Drug Saf 15:291\u2013303. https:\/\/doi.org\/10.1002\/pds.1200","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"3054_CR35","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJMC2119270\/SUPPL_FILE\/NEJMC2119270_DISCLOSURES.PDF","volume":"386","author":"S Collie","year":"2022","unstructured":"Collie S, Champion J, Moultrie H et al (2022) Effectiveness of BNT162b2 vaccine against omicron variant in South Africa. N Engl J Med 386:494\u2013496. https:\/\/doi.org\/10.1056\/NEJMC2119270\/SUPPL_FILE\/NEJMC2119270_DISCLOSURES.PDF","journal-title":"N Engl J Med"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-022-03054-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-022-03054-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-022-03054-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T19:40:22Z","timestamp":1668195622000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-022-03054-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,30]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["3054"],"URL":"https:\/\/doi.org\/10.1007\/s11739-022-03054-1","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,30]]},"assertion":[{"value":"3 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"FL and EM provided consultancies in protocol preparation for epidemiological studies and data analyses for Angelini, Pfizer, and GSK. AR, IG, AM, PLA, and CC provided clinical consultancies for Angelini, Pfizer, and GSK. DF has no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"According to a by-law on the classification and implementation of observational drug-related research, as issued by the Italian National Drug Agency (an entity belonging to the Italian Ministry of Health), the present study does not require approval by an Ethics Committee in Italy (Italian Drug Agency note of 3 August 2007). This study followed the principles of the Declaration of Helsinki and compliant with the ENCePP (European Network of Centres for Pharmacoepidemiology and Pharmacovigilance) Guide on Methodological Standards in Pharmacoepidemiology.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The database is fully anonymized.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}